Patient-specific factors influence somatic variation patterns in von Hippel-Lindau disease renal tumours

Nature Communications

Volumn 7, Issue , 2016, Pages

  Fei, Suzanne S ^a   Mitchell, Asia D ^a   Heskett, Michael B ^a   Vocke, Cathy D ^b   Ricketts, Christopher J ^b   Peto, Myron ^a   Wang, Nicholas J ^c   Sönmez, Kemal ^c   Linehan, W Marston ^b   Spellman, Paul T ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c Oregon Health and Science University Department of Biomedical Engineering   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRINUCLEOTIDE; CARCINOGEN;

CANCER; CHROMOSOME; DISEASE INCIDENCE; DISEASE TREATMENT; ENVIRONMENTAL FACTOR; GENETIC ANALYSIS; GENETIC VARIATION; MUTATION; TUMOR;

ADULT; ARTICLE; CLINICAL ARTICLE; COPY NUMBER VARIATION; FEMALE; GENE SEQUENCE; GENOME ANALYSIS; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; HUMAN TISSUE; KIDNEY TUMOR; MALE; MIDDLE AGED; NUMERICAL CHROMOSOME ABERRATION; SOMATIC COPY NUMBER VARIANT; SOMATIC MUTATION; SOMATIC SINGLE NUCLEOTIDE VARIANT; VON HIPPEL LINDAU DISEASE; YOUNG ADULT; DNA MUTATIONAL ANALYSIS; ENVIRONMENTAL EXPOSURE; GENETICS; HUMAN CHROMOSOME; HUMAN GENOME; MUTATION; PATHOLOGY; RENAL CELL CARCINOMA; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALIA;

ADULT; CARCINOGENS, ENVIRONMENTAL; CARCINOMA, RENAL CELL; CHROMOSOMES, HUMAN; DNA COPY NUMBER VARIATIONS; DNA MUTATIONAL ANALYSIS; ENVIRONMENTAL EXPOSURE; FEMALE; GENOME, HUMAN; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; VON HIPPEL-LINDAU DISEASE; YOUNG ADULT;

EID: 84968884300     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms11588     Document Type: Article

References (39)

1. Merlo, L. M. F., Pepper, J. W., Reid, B. J. & Maley, C. C. Cancer as an evolutionary and ecological process. Nat. Rev. Cancer 6, 924-935 (2006).
2. Hanahan, D., Weinberg, R. A. & Francisco, S. The hallmarks of cancer review university of California at San Francisco. Cell 100, 57-70 (2000).
3. Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646-674 (2011).
4. Nik-Zainal, S. et al. Mutational processes molding the genomes of 21 breast cancers. Cell 149, 979-993 (2012).
5. Creighton, C. J. et al. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 499, 43-49 (2013).
6. Nickerson, M. L. et al. Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors. Clin. Cancer Res. 14, 4726-4734 (2008).
7. Stolle, C. et al. Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene. Hum. Mutat. 12, 417-423 (1998).
8. Walther, M. M. et al. Prevalence of microscopic lesions in grossly normal renal parenchyma from patients with Von Hippel-Lindau disease, sporadic renal cell carcinoma and no renal disease: clinical implications. J. Urol. 154, 2010-2015 (1995).
9. Duffey, B. G. et al. The relationship between renal tumor size and metastases in patients with von Hippel-Lindau disease. J. Urol. 172, 63-65 (2004).
10. Gerlinger, M. et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med. 366, 883-892 (2012).
11. Gerlinger, M. et al. Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing.Nat. Genet. 46, 225-233 (2014).
12. Fisher, R. et al. Development of synchronous VHL syndrome tumors reveals contingencies and constraints to tumor evolution. Genome Biol. 15, 433 (2014).
13. Beroukhim, R. et al. Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney. Cancer Res. 69, 4674-4681 (2009).
14. Dworkin, A. M. et al. Germline variation controls the architecture of somatic alterations in tumors. PLoS Genet. 6, e1001136 (2010).
15. Fujimoto, A. et al. Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators. Nat. Genet. 44, 760-764 (2012).
16. Martincorena, I. et al. High burden and pervasive positive selection of somatic mutations in normal human skin. Science 348, 880-886 (2015).
17. Cazier, J.-B. et al. Whole-genome sequencing of bladder cancers reveals somatic CDKN1A mutations and clinicopathological associations with mutation burden. Nat. Commun. 5, 3756 (2014).
18. Wang, K. et al. Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer. Nat. Genet. 46, 573-582 (2014).
19. Lawrence, M. S. et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 499, 214-218 (2013).
20. Alexandrov, L. B., Nik-Zainal, S., Wedge, D. C., Campbell, P. J. & Stratton, M. R. Deciphering signatures of mutational processes operative in human cancer. Cell Rep. 3, 246-259 (2013).
21. Alexandrov, L. B. et al. Signatures of mutational processes in human cancer. Nature 500, 415-421 (2013).
22. Helleday, T., Eshtad, S. & Nik-Zainal, S. Mechanisms underlying mutational signatures in human cancers.Nat. Rev. Genet. 15, 585-598 (2014).
23. Alexandrov, L. B. & Stratton, M. R. Mutational signatures: the patterns of somatic mutations hidden in cancer genomes. Curr. Opin. Genet. Dev. 24, 52-60 (2014).
24. Gehring, J. S., Fischer, B., Lawrence, M. & Huber, W. Somaticsignatures: inferring mutational signatures from single nucleotide variants. Bioinformatics 31, 3673-3675 (2015).
25. Webster, A. R., Richards, F. M., MacRonald, F. E., Moore, A. T. & Maher, E. R. An analysis of phenotypic variation in the familial cancer syndrome von Hippel-Lindau disease: evidence for modifier effects. Am. J. Hum. Genet. 63, 1025-1035 (1998).
26. Ong, K. R. et al. Genotype-phenotype correlations in von Hippel-Lindau disease. Hum. Mutat. 28, 143-149 (2007).
27. Maranchie, J. K. et al. Solid renal tumor severity in von hippel lindau disease is related to germline deletion length and location. Hum. Mutat. 23, 40-46 (2004).
28. Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754-1760 (2009).
29. Li, H. et al. The sequence alignment/map format and SAMtools. Bioinformatics 25, 2078-2079 (2009).
30. Picard Tools v1.51 at http://picard.sourceforge.net/ (2011).
31. McKenna, A. et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297-1303 (2010).
32. DePristo, M. A. et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat. Genet. 43, 491-498 (2011).
33. Xi, R., Luquette, J., Hadjipanayis, A., Kim, T.-M. & Park, P. J. BIC-seq: a fast algorithm for detection of copy number alterations based on high-throughput sequencing data. Genome Biol. 11, O10 (2010).
34. Cibulskis, K. et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat. Biotechnol. 31, 213-219 (2013).
35. Sherry, S. T. et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 29, 308-311 (2001).
36. Exome Variant Server, (ESP), NHLBI GO Exome Sequencing Project. Seattle, WA at 'http://evs.gs.washington.edu/EVS/' Variants downloaded on 11 September 2012.
37. Fu, W. et al. Analysis of 6,515 exomes reveals the recent origin of most human protein-coding variants. Nature 493, 216-220 (2013).
38. Forbes, S. A. et al. COSMIC: mining complete cancer genomes in the catalogue of somatic mutations in cancer. Nucleic Acids Res. 39, D945-D950 (2011).
39. Carter, S. L. et al. Absolute quantification of somatic DNA alterations in human cancer. Nat. Biotechnol. 30, 413-421 (2012).